496841-90-8Relevant articles and documents
INHIBITORS OF HEPATITIS C VIRUS POLYMERASE
-
Paragraph 548; 549, (2016/10/11)
The present invention provides, among other things, compounds represented by the general Formula I: (I) and pharmaceutically acceptable salts thereof, wherein L and A (and further substituents) are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.
ARALKYL AND ARALKYLIDENE HETEROCYCLIC LACTAMS AND IMIDES
-
Page/Page column 51-52, (2008/06/13)
The present invention relates to compounds of the formula (I) wherein R1, R2, R3, X, Y and the dashed line are defined in the specification, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use as psychotherapeutic agents.